TCS, HDFCBANK, SBI Liquid Fund (G)
Gufic Biosciences Ltd.
Gufic Biosciences
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 04 06 2021 | Audited Results & Final Dividend Inter alia, to consider and approve 1. Allotment of 1,91,14,506 Equity Shares of Re. 1/-each to the shareholders of Gufic Lifesciences Private Limited (Transferor Company) pursuant to the order passed by Hon’ble National Company Law Tribunal (NCLT) Ahmedabad bench dated December 31, 2020 and NCLT Mumbai bench dated March 11, 2021, sanctioning the Scheme of Amalgamation of the Transferor Company with Gufic Biosciences Limited and their respective shareholders and creditors. |
| 11 08 2021 | Quarterly Results |
| 03 11 2021 | Quarterly Results |
| 09 02 2022 | Quarterly Results |
| 20 05 2022 | Final Dividend & Audited Results |
| 11 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 10 02 2023 | Quarterly Results |
| 29 05 2023 | Final Dividend & Audited Results |
| 11 08 2023 | Employees Stock Option Plan & Quarterly Results |
| 01 09 2023 | Preferential Issue of shares |
| 09 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
News
No News data available
